Oncimmune Holdings PLC (LON:ONC), a Leading Global Immunodiagnostics Group, will be keynoting the China BioMed Innovation and Investment Conference (CBIIC) on Sunday 22nd September 2019, at 9:00 am CST (2:00 am
Oncimmune Holdings plc (LON:ONC), a leading global immunodiagnostics group, today welcomed the presentation of data today by Professor Frank Sullivan (Chief Investigator on the ECLS trial) which has demonstrated the
Oncimmune Holdings PLC (LON:ONC), a Leading Global Immunodiagnostics Group, will be presenting at the Solebury Trout European Biotech Investor Day today, Thursday 1st August 2019, at 11.30 am EDT (16:30 BST) in New
Dr Adam M Hill, CEO of Oncimmune commented: “Today’s announcement further demonstrates the success of our partnership with Sabartech for the distribution of EarlyCDT Lung across the Iberian Peninsula. The news highlights the growing momentum behind our business
Commercialisation partnership with R-Pharm for use of EarlyCDT® Lung in screening for early detection of lung cancer Oncimmune to receive revenues of at least £5 million, including milestone payments of up to £2.75 million; R-Pharm
Dr Adam M Hill, CEO of Oncimmune commented: “In October 2018, I undertook to bring to investors a strategic partnership which fully realises the value of EarlyCDT Lung in the US, exhibiting a
Oncimmune Holdings PLC (LON:ONC), a leading global immunodiagnostics group, today provided the following business update for the year ended 31 May 2019. ECLS On 4 June 2019, the Company announced
When top cancer doctors gathered for the annual meeting of the American Society of Clinical Oncology last weekend, faster detection of the illness was on medics’ minds. Nottingham-based Oncimmune, listed
Oncimmune Holdings plc (LON: ONC), a leading global immunodiagnostics group, today announced positive top line results from the Early Cancer Detection Test – Lung Cancer Scotland study. The ECLS study,
Oncimmune Holdings plc (LON: ONC), a leader in the development, manufacture and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer, today announced that its distributor for
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
